Skip to main content Skip to main content
HRZN · Business Development Company

Horizon Technology Finance Corp


Inside Horizon Technology Finance Corp’s $646M private-credit portfolio — 152 portfolio holdings disclosed in SEC filings.

152
Portfolio Holdings
$646M
Total Fair Value

Filing Information

Filing Date
2026-05-05
Last Updated
2026-05-12

Portfolio Composition

Portfolio-wide breakdown by fair value across this BDC’s full Schedule of Investments. Source: SEC EDGAR (public).

152
Unique Borrowers
Other Debt
100.0%

Top Portfolio Holdings

CompanySectorInvestmentCouponMaturityCostFair Value
NonaffiliateDebtInvestmentsTechnologyKodiakRoboticsSoftwareTermLoanOneMember2030-01-01$14,625,000$14,625,000
NonaffiliateDebtInvestmentsLifeScienceOssioIncMedicalDeviceTermLoanOneMember2031-01-20$12,365,000$12,365,000
NonaffiliateDebtInvestmentsLifeScienceLongGrovePharmaceuticalsBiotechnologyTermLoanMember2031-02-27$10,168,000$10,168,000
NonaffiliateDebtInvestmentsLifeScienceCastleCreekBiosciencesBiotechnologyTermLoanOneMember2028-03-01$9,955,000$9,955,000
NonaffiliateDebtInvestmentsHealthcareElligoHealthResearchIncSoftwareTermLoanOneMember2027-10-01$9,948,000$9,948,000
NonaffiliateDebtInvestmentsLifeScienceScientiaVascularIncMedicalDeviceTermLoanTwoMember2030-07-01$9,895,000$9,895,000
NonaffiliateDebtInvestmentsLifeScienceScientiaVascularIncMedicalDeviceTermLoanOneMember2030-07-01$9,895,000$9,895,000
NonaffiliateDebtInvestmentsLifeScienceOnkosSurgicalIncMedicalDeviceTermLoanOneMember2030-01-01$9,882,000$9,882,000
NonaffiliateDebtInvestmentsLifeScienceOnkosSurgicalIncMedicalDeviceTermLoanTwoMember2030-01-01$9,882,000$9,882,000
NonaffiliateDebtInvestmentsLifeScienceSonexHealthIncMedicalDeviceTermLoanTwoMember2030-04-01$9,849,000$9,849,000
NonaffiliateDebtInvestmentsTechnologyBriteCoreHoldingsIncSoftwareTermLoanOneMember2031-01-01$9,837,000$9,837,000
NonaffiliateDebtInvestmentsTechnologySambaTVIncSoftwareTermLoanOneMember2030-12-01$9,823,000$9,823,000
NonaffiliateDebtInvestmentsLifeSciencePelthosTherapeuticsIncBiotechnologyTermLoanTwoMember2031-01-31$9,785,000$9,785,000
NonaffiliateDebtInvestmentsLifeSciencePelthosTherapeuticsIncBiotechnologyTermLoanOneMember2031-01-31$9,785,000$9,785,000
NonaffiliateDebtInvestmentsLifeScienceSonexHealthIncMedicalDeviceTermLoanOneMember2030-04-01$9,749,000$9,749,000
NonaffiliateDebtInvestmentsTechnologyMasteryPrepLLCSoftwareTermLoanTwoMember2029-07-01$7,437,000$7,437,000
NonaffiliateDebtInvestmentsTechnologySambaTVIncSoftwareTermLoanTwoMember2030-12-01$7,424,000$7,424,000
NonaffiliateDebtInvestmentsLifeScienceOssioIncMedicalDeviceTermLoanTwoMember2031-01-20$7,420,000$7,420,000
NonaffiliateDebtInvestmentsTechnologyBriteCoreHoldingsIncSoftwareTermLoanTwoMember2031-01-01$7,415,000$7,415,000
NonaffiliateDebtInvestmentsHealthcareGTMedicalTechnologiesIncOtherHealthcareServicesTermLoanThreeMember2029-10-01$7,414,000$7,414,000
NonaffiliateDebtInvestmentsTechnologyMasteryPrepLLCSoftwareTermLoanOneMember2029-07-01$7,387,000$7,387,000
NonaffiliateDebtInvestmentsTechnologyKodiakRoboticsSoftwareTermLoanThreeMember2030-01-01$7,312,000$7,312,000
NonaffiliateDebtInvestmentsTechnologyKodiakRoboticsSoftwareTermLoanTwoMember2030-01-01$7,312,000$7,312,000
NonControlledAffiliateDebtInvestmentsHoundLabsIILLCDiagnosticsTermLoanOneMember2027-07-01$7,008,000$6,809,000
NonaffiliateDebtInvestmentsLifeScienceCastleCreekBiosciencesBiotechnologyTermLoanTwoMember2028-03-01$5,475,000$5,475,000

Loan-Pricing Trend

Fair-value-weighted average credit spread and average mark across this BDC’s Schedule-of-Investments debt holdings, by filing quarter. Spread and mark are shown in the units reported in the filing. Source: SEC EDGAR (public).

QuarterPriced LoansWtd-Avg SpreadAvg MarkDebt Fair Value
2022-06-300$123K
2022-09-300150.0$52K
2022-12-310150.0$59K
2023-03-310150.0$56K
2023-06-300150.0$55K
2023-09-300150.0$77K
2023-12-310150.0$44K
2024-03-310$45K
2024-06-300$44K
2024-09-300$26K
2024-12-310150.0$24K
2025-03-310150.0$35K
2025-06-300$579M
2025-09-300$549M
2025-12-310$596M
2026-03-310$646M

Marks reflect each BDC’s own fair-value estimates as reported to the SEC, not traded prices. Private-credit loans are predominantly Level 3 under ASC 820 — valued from unobservable inputs and determined in good faith by each BDC’s board, so figures are estimates as of the filing date and are not directly comparable across managers. Informational only; not investment advice or a valuation.

About Horizon Technology Finance Corp

Horizon Technology Finance Corp (HRZN) is a publicly traded Business Development Company (BDC) — essentially a publicly listed fund that lends money to mid-sized private companies. In plain English: BDCs raise money from public investors and lend it to businesses that are too small for Wall Street banks. By law, they must pay out at least 90% of their profits as dividends, which is why BDC yields are often 8–12%. Horizon Technology Finance Corp discloses its full loan portfolio through SEC filings.

Learn how BDCs work

New to business development companies? These free Oxford Ledge lessons explain the mechanics behind the figures on this page: What is a BDC?, reading a Schedule of Investments, and non-accruals — the #1 BDC credit metric.

Explore other BDCs

Compare HRZN with other Business Development Companies and their loan portfolios: Ares Capital Corporation (ARCC) · Ares Strategic Income Fund (AGTC) · Bain Capital Specialty Finance (BCSF) · Barings BDC Inc (BBDC) · BlackRock TCP Capital Corp (TCPC) · Blackstone Secured Lending Fund (BXSL) · Blue Owl Capital Corp (OBDC) · Blue Owl Capital Corp II (OBDE) · Capital Southwest Corporation (CSWC) · Carlyle Secured Lending (CGBD) · CION Investment Corp (CION) · Crescent Capital BDC Inc (CCAP) · Fidus Investment Corporation (FDUS) · Franklin BSP Lending Corp (FBLK) · FS KKR Capital Corp (FSK) · Gladstone Capital Corporation (GLAD) · Gladstone Investment Corporation (GAIN) · Goldman Sachs BDC Inc (GSBD)